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Background: The effects of a local anesthetic delivered through a catheter inserted
in the extrapleural region by a surgeon and an analgesic agent given systemically on
pain after thoracotomy were assessed.
Methods: The patients in group I (n  25) had a catheter inserted between the
parietal pleura and the endothoracic fascia by a surgeon, and 0.5% bupivacaine was
given through this catheter. Another 25 patients (group II) had metamizol given
intravenously. Respiratory function tests, arterial blood gases, range of shoulder
motion, and postoperative pain were evaluated for each group. Bupivacaine and
metamizol were given just before finishing the thoracotomy and then repeated every
4 hours for 3 days.
Results: There was no statistical difference in arterial blood gases between the
groups (P  .05). There were statistically significant differences in the respiratory
function tests, range of shoulder motion, and visual analogue scale (P  .05)
between the groups. Group I had fewer complications than group II. There was no
mortality in either group.
Conclusions: Bupivacaine given through a catheter to the extrapleural region before
finishing thoracotomy is substantially beneficial for the prevention of postoperative
pain and reduction of postoperative complications.
Controlling pain after thoracotomy is important for patient comfortand the prevention of possible complications during the postoper-ative period. Pain after thoracotomy hinders deep breathing andeffective cough in patients. Accordingly, lungs cannot expand andthis leads to atelectasis and intrapulmonary shunting with compli-cations.
The aim of this study was to assess the analgesic effects of a long-acting local
anesthetic (0.5% bupivacaine) given through a catheter inserted in the paravertebral
region extrapleurally before finishing thoracotomy versus a systemic analgesic agent
(metamizol) and their effects on respiratory functions.
Material and Methods
This study was performed between January 1998 and December 2001. The patients in group
I (n  25) had a catheter inserted between the parietal pleura and the endothoracic fascia by
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a surgeon and 0.5% bupivacaine was given, adjusted according to
the weight (0.1 mg/kg) and completed to 10 mL with saline,
through this catheter. The other 25 patients (group II) had met-
amizol (1 g) given intravenously. There were 38 male patients and
12 female patients; their average age was 46.75  13.56 years
(range 21-70). The patients were randomly selected.
All these doses were repeated every 4 hours. The catheter was
removed after 3 days and systemic analgesic, metamizol, was
discontinued.
Forced vital capacity (FVC), forced expiratory volume in 1
second (FEV1), and blood gases were measured preoperatively and
postoperatively. Surgical procedures were performed by a standard
thoracotomy (Table 1).
Visual analogue scale (VAS) was used for pain scoring. Pa-
tients were informed about the procedure before the operation and
their consent was obtained. Pain intensity was assessed just after
the patient woke up and then at hours 4, 8, 12, 16, 20, 24, 48, and
72. Samples for blood gas analyses were obtained at hours 1, 2, 24,
48, and 72. FVC and FEV1 values were measured at hours 24, 48,
and 72 and on day 7.
Chest radiographs were obtained in the first 3 days in all
patients to evaluate possible complications. Range of shoulder
motion (ROM) was measured during the first 5 days.
Surgical Technique
Before finishing the thoracotomy, a 16-gauge catheter needle was
extended out of the thorax through the posterior axillary line in the
eighth intercostal space. The catheter was passed through the
needle and after moving it into the thorax, the needle was removed.
A small hole was opened on the parietal pleura in the paravertebral
region through the third intercostal space. Through this hole an
extrapleural tunnel was opened to the eighth intercostal space by
sterilized biopsy forceps of flexible bronchoscope. The catheter tip
was pulled upward with biopsy forceps. The proximal and distal
holes in the parietal pleura were deeply closed with 3-0 absorbable
sutures to prevent external drug leaks (Figure 1).
Statistical Analysis
Statistical analyses were made by using Student t test (FVC, FEV1,
ROM, and blood gases), Mann-Whitney U test (pain intensity at
rest and when coughing), and significance test for the difference
between the 2 percentages (age). A P value less than .05 was
considered significant.
Results
There was no statistically significant difference between the
groups in age and sex (P  .05). There was no statistical
significant difference in respiratory functions between both
groups preoperatively (P  .05). A decrease in FVC and
FEV1 values was found in both groups when compared to
the preoperative values. On the first day when the mean
FVC and FEV1 values were compared with the preoperative
values, in group I FVC was 54% and FEV1 was 55% and in
group II, FVC was 42% and FEV1 was 38% of the preop-
erative values. In both groups, FVC and FEV1 values grad-
ually increased in subsequent days. On day 7 postopera-
tively, group I had 86% and 90% and group II recovered to
70% and 58%, respectively, compared with the preoperative
values (P  .05; Table 2). Improvement in postoperative
respiratory functions was more rapid in the paravertebral
analgesia group when compared with the systemic analgesia
group.
A statistically significant decrease was observed in these
values between the groups for VAS. Pain levels were sta-
tistically significant in both groups (P  .05; Table 3). In
the paravertebral analgesia group the postoperative pain was
less than the systemic analgesia group during either the rest
or coughing.
When the patients were asked for abduction until the
pain occurred during the postoperative 5 days, the degree of
abduction angle (range of motion) was found to be signif-
icantly higher in the paravertebral analgesia group (P .05;
Table 4).
There was no statistically significant difference in arte-
rial blood gases between the 2 groups (P  .05).
Figure 1. The schematic illustration of paravertebral catheter
insertion.
TABLE 1. Surgical procedures*
Surgical procedures Group I Group II
Lobectomy 3 2
Bilobectomy 4 4
Pneumonectomy 2 2
Metastasectomy 3 3
Cystotomy plus capitonnage 7 7
Resections of bullae and blebs 6 7
Total 25 25
*Thirty-two patients had left thoracotomy and 18 patients had right thora-
cotomy.
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In group II 3 patients developed atelectasis, 1 patient had
atrial fibrillation, and 4 patients had pneumothorax with a
ratio of 15% to 20%. One of the patients who had atelectasis
required bronchoscopy and intensive physical therapy. In
group I 1 patient had hypotension accompanied by brady-
cardia after the first dose of bupivacaine. No other compli-
cations occurred because of the bupivacaine infusion
through paravertebral catheter.
Discussion
Effective analgesia and blockade of perioperative stress
response may improve the outcome and accelerate recovery
after thoracic surgery.1 The earliest change in respiratory
mechanics during the postoperative period is the decrease in
FEV1 and FVC. These changes may be seen before any
change in functional residual capacity is observed. De-
creased functional residual capacity and alveolar collapse
during anesthesia may be further impaired by restrictive
ventilation caused by postoperative pain and abnormal res-
piration pattern.2 When airways are obstructed or atelectasis
develops, air flow to this region is impaired. Secretions
accumulate and a focus for infections may occur. There is a
positive correlation between postoperative pulmonary com-
plications and respiratory function tests.3 Systemic analge-
sics may be used for pain after thoracotomy.
Currently, epidural anesthesia is the gold standard for
postoperative pain management in thoracic surgery but hy-
potension, muscle weakness, and urinary retention are un-
wanted effects following epidural blockade.4
Intercostal nerve blocks can be performed either intra-
operatively or postoperatively. They provide good relief
lasting 6 to 12 hours and need to be repeated.1 An alternate
route is the administration of local anesthetic through an
intrapleural catheter. This is done by placing a catheter
between the parietal and visceral pleura and running the
infusion either intermittently or continuously. One of the
problems is the loss of local anesthetic solution through the
chest tubes; these tubes need to be clamped intermittently
for this technique to be effective.1 It is not safe to clamp
chest tubes, which provide drainage of hemorrhage and air
and lung patency for expansion, during the postoperative
period. Also, there are some reports suggesting that inter-
pleural practices are not safe.5
In our study the dose of bupivacaine was less than toxic
limits. Patients received a mean daily dose of 38.3 mg
bupivacaine, and no systemic side effects were observed
except in 1 patient who developed bradycardia and hypo-
tension, which spontaneously resolved within 15 minutes.
In the literature no toxicity was found when doses approx-
imately 10-fold higher than ours (360 mg) were adminis-
TABLE 2. FVC (mL) and FEV (mL) values on postoperative day 1, 2, 3, and 7
Preop Day 1 Day 2 Day 3 Day 7
FVC (paravertebral) 3370.2 543.7 1793.0 564.7 1927.4 374.7 2398.9 713.8 2897.7 683.4
FVC (systemic) 3482.1 324.4 1176 327.9 1339.3 132.8 1943.6 318.6 2216 423.3
P value .05 .05 .05 .05 .05
FEV1 (paravertebral) 3143.5 745.6 1623.5 375.9 1893.8 436.4 2276.9 653.1 2792.7 618.7
FEV1 (systemic) 3312.2 516.3 1083 163.6 1280.2 168.5 1872.2 322.5 2143 473.2
P value .05 .05 .05 .05 .05
TABLE 3. The mean pain scores of the patients at rest and when coughing according to VAS during the first 72 hours
Upon rising
Hour
4 8 12 16 20 24 48 72
Paravertebral—rest 4.80 1.0 3.76 0.9 3.57 0.8 3.78 0.8 3.16 0.7 2.82 0.9 2.70 0.3 1.89 9.2 1.23 0.1
Systemic—rest 6.93 0.7 6.22 0.3 5.87 0.3 5.01 1.0 4.97 1.0 4.63 1.1 3.80 0.7 3.10 0.9 26.0 0.7
P value .05 .05 .05 .05 .05 .05 .05 .05 .05
Paravertebral—cough 5.73 0.4 4.68 0.9 4.01 0.4 4.18 0.9 4.08 0.7 3.57 0.8 3.48 0.8 2.58 0.6 1.89 0.9
Systemic—cough 7.76 0.2 6.96 0.8 6.38 1.1 5.86 0.7 5.53 0.9 4.73 0.7 4.03 1.0 2.82 0.7 2.86 5
P value .05 .05 .05 .05 .05 .05 .05 .05 .05
TABLE 4. The mean range of shoulder motion in postoperative 5 days
Day 1 Day 2 Day 3 Day 4 Day 5
Group I 56.2 6.8 72.0 17.3 99.5 14.8 131.4 17.8 139.0 17.6
Group II 40.6 0.4 40.2 11.0 70.6 17.7 98.4 18.0 108.3 20.6
P value .05 .05 .05 .05 .05
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tered.6 In the studies where bupivacaine was administered
by an interpleural catheter, it was suggested that toxicity
resulted from the systemic absorption of bupivacaine be-
cause of the rich vascularity of pleura.7 When blood levels
exceed 2.0 to 4.0 g/mg, toxic effects involving the central
nervous system and cardiovascular system may occur.7 Dry
mouth, reversible myosis caused by stellate ganglion block-
ade, and ptosis have been reported.8 Many studies have
shown that bupivacaine is fairly effective, with no associ-
ated toxicity.3,6,8,9
VAS is one of the most reliable methods used for eval-
uating pain levels.10 As patients were informed about rating
their pain levels in the preoperative period, VAS could
easily be used. Administering anesthetic agent during the
operation in group I patients provided early pain control and
reduced despair and nervousness, which is important for
pain control.
Local anesthetics will block the volley of nerve impulses
in the unmyelinated C fibers and prevent prolonged wide-
spread increase in the spinal cord dorsal horn. This is known
as “windup” phenomenon or central sensitization. Even
large doses of opioids alone will not be able to prevent this
phenomenon or, once it is established, they will not be able
to counteract it effectively.1 Early pain control avoids the
windup phenomenon and central sensitization.1 Pain relief
provided by inserting a catheter in the extrapleural region
seems to be more effective compared with metamizol. The
pulmonary complications resulted from the lack of effective
coughing due to the pain in group II patients.
Another cause of pain after thoracotomy is the organs
innervated by sympathetic nerves and visceral pleura.3 The
insertion of the catheter next to the sympathetic nerves
reduces these types of pain and avoids an arrhythmic pattern
observed in the postoperative period due to sympathetic
activation. In this study 1 patient in group I had bradycardia,
which resolved spontaneously in 15 minutes.
Many factors are involved in the occurrence of the re-
striction in lungs following thoracotomy. Changes in pul-
monary functions result from lung resection, atelectasis, and
volume loss due to pneumothorax and also inspiratory mus-
cle dysfunction.6 We had a similar observation in terms of
a decrease in FVC and FEV1 values during the postopera-
tive period in both groups. Studies assessing the effects of
pain following thoracotomy have shown substantial im-
provements in postoperative pulmonary functions after in-
tercostal blockade.1
The mechanism of action of extrapleural regional anes-
thesia depends primarily on diffusion of the analgesic agent
into the paravertebral region.11 Local anesthetic agents af-
fect not only ventral nerve roots but also afferent fibers
of posterior primary ramus. Posterior ligaments of pos-
terior primary ramus innervate posterior spinal muscles
and skin. These ligaments were traumatized during the
posterolateral thoracotomy.12 The procedure involving
intermittent administration of anesthetic agent to this
region through a catheter inserted in extrapleural region
creates an anesthetic region in the skin due to the block-
ade of this region by the anesthetic agent. The depth and
width of this anesthetic region depend on diffusion of the
agent in the extrapleural region. This finding is one of the
method’s objective criteria for providing pain relief after
thoracotomy.
Pain relief during the postoperative period may reduce
postoperative complications with early ambulation of pa-
tients. The painless arm abduction and the elevation degree
were greater in group I compared with group II patients.
This observation explains the lack of complications in group
I; it also resulted in an increase in the patients’ self-confi-
dence because of the fact that they carried their own chest
drainage tubes themselves.
This study shows that regional anesthesia provided by a
long-acting local anesthetic bupivacaine through a catheter
surgically inserted into extrapleural region is effective in
postoperative pain control. This safe, cheap, and effective
method shows a decrease in possible lung complications
and exerts a positive effect on respiratory functions follow-
ing thoracotomy.
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